GILD vs RVMD
Gilead Sciences, Inc. - Common Stock · Revolution Medicines, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | GILD | RVMD |
|---|---|---|
| Price | $159.08 | $186.22 |
| Market Cap | $197.25B | $39.91B |
| P/E | 23.18 | — |
| P/B | 16.68 | 15.31 |
| P/S | 6.70 | — |
| ROE | 71.9% | -43.4% |
| Net Margin | 28.9% | — |
| Gross Margin | — | — |
| Revenue Growth | 2.4% | — |
| Dividend Yield | 1.99% | — |
| EPS | $6.86 | -$5.28 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.